OptimizeRx (NASDAQ: OPRX), a leading provider of healthcare technology solutions for life sciences companies, announced that it has entered into a $35 million senior secured credit facility with Fifth Third Bank. The facility comprises a $25 million term loan and a $10 million revolving credit facility, which was undrawn at closing. Roth Capital Partners served as financial advisor for the transaction.
This credit facility provides OptimizeRx with additional capital to support its strategic growth initiatives, including the continued development of its AI-driven tools such as the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT). These technologies enable timely, relevant, and hyper-local engagement between life science brands and healthcare providers (HCPs) and patients. By bridging the gap between HCP and direct-to-consumer strategies, OptimizeRx empowers brands to create synchronized marketing solutions that drive faster treatment decisions and improved patient outcomes.
The announcement highlights the company's commitment to privacy-safe, patient-centric technology, ensuring that every interaction is designed to make a meaningful impact. OptimizeRx partners with some of the world's leading pharmaceutical and life sciences companies to transform the healthcare landscape. Headquartered in Waltham, Massachusetts, the company focuses on delivering life-changing therapies to the right patients at the right time.
Details of the transaction are available in the full announcement at https://ibn.fm/G0Fj3. The credit facility is expected to enhance OptimizeRx's financial flexibility as it continues to innovate in the healthcare technology space.
OptimizeRx is redefining how life science brands connect with patients and healthcare providers through its comprehensive platform. The company’s tools leverage artificial intelligence to deliver targeted, effective marketing solutions that improve patient outcomes. For more information about OptimizeRx and its offerings, visit www.optimizerx.com.
The securing of this credit facility comes at a time when the healthcare technology sector is experiencing significant growth, driven by increasing demand for digital health solutions and personalized patient engagement. OptimizeRx is well-positioned to capitalize on these trends, with its innovative platform and strong partnerships with leading life sciences companies.
